方法文章

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

DOI:

10.3791/59873

2019年8月14日

本文内容

摘要

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The characterization of circulating tumor cells (CTCs) is a popular topic in translational research. This protocol describes a semi-automatic immunofluorescence (IF) assay for PD-L1 characterization and enumeration of CTCs in non-small cell lung cancer (NSCLC) patient samples.

摘要

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Circulating tumor cells (CTCs) derived from the primary tumor are shed into the bloodstream or lymphatic system. These rare cells (1−10 cells per mL of blood) warrant a poor prognosis and are correlated with shorter overall survival in several cancers (e.g., breast, prostate and colorectal). Currently, the anti-EpCAM-coated magnetic bead-based CTC capturing system is the gold standard test approved by the U.S. Food and Drug Administration (FDA) for enumerating CTCs in the bloodstream. This test is based on the use of magnetic beads coated with anti-EpCAM markers, which specifically target epithelial cancer cells. Many studies have illustrated that EpCAM is not the optimal marker for CTC detection. Indeed, CTCs are a heterogeneous subpopulation of cancer cells and are able to undergo an epithelial-to-mesenchymal transition (EMT) associated with metastatic proliferation and invasion. These CTCs are able to reduce the expression of cell surface epithelial marker EpCAM, while increasing mesenchymal markers such as vimentin. To address this technical hurdle, other isolation methods based on physical properties of CTCs have been developed. Microfluidic technologies enable a label-free approach to CTC enrichment from whole blood samples. The spiral microfluidic technology uses the inertial and Dean drag forces with continuous flow in curved channels generated within a spiral microfluidic chip. The cells are separated based on the differences in size and plasticity between normal blood cells and tumoral cells. This protocol details the different steps to characterize the programmed death-ligand 1 (PD-L1) expression of CTCs, combining a spiral microfluidic device with customizable immunofluorescence (IF) marker set.

引言

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Tumor antigen-specific cytotoxic T-lymphocytes (CTLs) play a crucial role in the response to cancers through a process known as cancer "immune surveillance". Their anti-tumor functions are enhanced by immune checkpoint blockade antibodies such as CTLA-4 inhibitors and PD-1/PD-L1 inhibitors. In non-small cell lung cancer (NSCLC), anti-PD-1/PD-L1 therapies result in response rates ranging from 0%-17% in patients with PD-L1-negative tumors and 36%-100% in those expressing PD-L1. The robust responses to PD-1/PD-L1 blockade observed in melanoma and NSCLC are shown by evidence of improved overall response rate (RR), durable clinical benefits, and progression-free su....

访问受限。请登录或开始试用以查看此内容。

方案

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Samples were prospectively collected within the framework of the CIRCAN ("CIRculating CANcer") cohort based at the Lyon University Hospital following patient written consent. This study was integrated into the CIRCAN_ALL cohort. The study CIRCAN_ALL was recognized as non-interventional by the CPP South-East IV dated 04/11/2015 under the reference L15-188. An amended version was recognized as non-interventional on 20/09/2016 under reference L16-160. The CIRCAN_ALL study was declared to the IT and freedom correspondent of the Hospices Civils de Lyon on 01/12/2015, under the reference 15-131. Blood collection was performed when physicians observed the earliest in....

访问受限。请登录或开始试用以查看此内容。

结果

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The first pre-requisite was to obtain uncontaminated (infectious agent-free) collections of CTCs for tissue culture and avoid IF background generated. The decontamination protocol enabled cleaning of all the pipes and pumps, and it resulted in the collection of CTCs with a good recovery rate without bacterial contamination. The enriched samples were compared without and with the decontamination protocol workflow of the spiral microfluidic device. To validate the decontamination protocol, the A549 cell line was used in ab.......

访问受限。请登录或开始试用以查看此内容。

讨论

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Two major points were raised in the present study, the first with regards to performance of the workflow for its transfer to clinical applications, and the second concerning the decrease in subjectivity for the analysis of fluorescence images obtained.

A performant and optimized workflow for CTC enumeration was initially determined using customizable IF assay after cell enrichment via a CTC label-free microfluidic system (spiral microfluidic device). Using this workflow, a pilot study confirme.......

访问受限。请登录或开始试用以查看此内容。

披露

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Jean-Philippe Aurel and Kathryn Weiqi Li are employees of Biolidics company that produces instruments used in this article. The other authors have nothing to disclose.

致谢

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by research grants from AstraZeneca (London, United-Kingdom), Biolidics (Singapore) and the Ligue Contre le Cancer (Saone et Loire, France). The authors thank AstraZeneca and Biolidics companies for their financial support.

....

访问受限。请登录或开始试用以查看此内容。

材料

本文使用的材料清单
姓名公司目录编号评论
4',6-二脒基-2-phé尼龙哚 (DAPI)OzymeBLE 422801储存条件:+4 °C
BD Facs Clean – 5 LBD Biosciences340345漂白剂基清洁剂。储存条件:室温
漂白剂 1% 清洁液 100 mLBiolidicsCBB-F016012漂白剂。储存条件:室温
牛血清白蛋白 (BSA) 7.5%SigmaA8412储存条件:+4 °C
CD45 单克隆抗体(克隆 HI30) Alexa Fluor 647BioLegendBLE304020储存条件:+4 >C
CellProfiler 软件Broad Institute图像分析软件
离心装置Hettich4706储存条件: 室温
离心管 50 mL康宁430-829储存条件: 室温
离心管 15 mL生物利度CBB-F001004-25储存条件: 室温
ClearCell FX-1 系统BiolidicsCBB-F011002螺旋微流控装置。储存条件:室温
Coulter Clenz 清洁剂 – 5 LBeckman Coulter8448222通用清洁剂。储存条件:室温
CTChip FR1SBiolidicsCBB-FR001002微流控芯片。储存条件:室温
Cytospin 4ThermoFisherA78300003储存条件:室温
稀释剂添加剂试剂 – 20 mL生物利度CBB-F016009储存条件:+4 °C
EZ Cytofunnels ThermoFisherA78710003带棉花的样品室。储存条件:室温
FcR 封闭剂Miltenyi Biotec130-059-901储存条件:+4 °C
胎牛血清 (FCS)Gibco10270-106储存条件:+4 °C
FluoromountSigmaF4680安装解决方案。储存条件:室温
Fungizone - 50 mgBristol-Myers-Squibb90129TB29抗真菌试剂。储存条件:+4 >C
FX1 输入吸管,带锁帽BiolidicsCBB-F013005吸管。储存条件:室温
KovaSlideDutscher50126腔室载玻片。储存条件: 室温
PanCK 单克隆抗体(克隆 AE1/AE3) Alexa Fluor 488ThermoFisher53-9003-80储存条件:+4 °C
多聚甲醛 16%ThermoFisher11490570固定液。储存条件:+4 >C
PD-L1 单克隆抗体(克隆 29E2A3) - 藻红蛋白BioLegendBLE329706储存条件:+4 °C
培养皿Dutscher632180储存条件:室温
磷酸盐缓冲盐水 (PBS)OzymeBE17-512F储存条件:+4 °C
磷酸盐缓冲盐水超纯 1x 级 – 1 L1st Base 实验室BUF-2040-1X1L储存条件:室温
Pluronic F-68 10%Gibco24040-032抗结合溶液。储存条件:室温
聚赖氨酸载玻片ThermoFisherJ2800AMNZ储存条件:室温
聚丙烯锥形管 50 mLFalcon352098储存条件:室温
RBC 裂解缓冲液 – 100 mLG Biosciences786-649储存条件:+4 °C
RBC 裂解缓冲液 – 250 mLG Biosciences786-650储存条件:+4 °C
重悬缓冲液 (RSB)生物利度CBB-F016003储存条件:+4 °C
Shandon Cytopsin4 离心机ThermoFisherA78300003专用离心机。储存条件: 室温
硅隔离器Grace bio-Labs664270储存条件: 室温
无菌 去离子水 – 100 mL1st Base LaboratoryCUS-4100-100ml储存条件: 室温
直式荧光显微镜 Axio Imager D1蔡司储存条件: 室温
手术 无菌袋装SPS 实验室98ULT01240储存条件: 室温
注射器 BD Discardit II 20 mL 无菌BD Biosciences300296储存条件: 室温
注射器过滤器 0.22 µm 33 mm 无菌ClearLine51732储存条件:室温
Zen lite 2.3 Lite 软件蔡司显微镜相关软件

参考文献

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Gandhi, L., et al. Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. The New England Journal of Medicine. 378 (22), 2078-2092 (2018).
  2. Paz-Ares, L., et al. Pembrolizumab plus Chemotherapy....

访问受限。请登录或开始试用以查看此内容。

重印与许可

申请许可以重复使用本 JoVE 文章的文本或图表

申请许可

标签

相关文章